 1

West, a company that provides innovative, high-quality products and solutions for the containment and delivery of injectable medicines, reported strong first-quarter performance.

# 2

Organic sales growth in the first quarter was 13%, driven by strong high-value product sales.

# 3

Adjusted earnings per share for the first quarter was up 10%, and the gross profit margin for proprietary products was 40.2%.

# 4

West's adjusted operating profit margin was 17.9%, up 180 basis points from the same period last year.

# 5

Operating cash flow for the first quarter was $57.1 million, an increase of $9.5 million compared to the same period last year.

# 6

West's full-year 2020 net sales guidance remains in a range of between $1.95 billion and $1.97 billion, with an estimated headwind of $26 million based on current foreign exchange rates.

# 7

West is committed to ensuring continuity of supply to its customers around the globe and supporting the healthcare industry in the development of COVID-19 solutions.

# 8

The company's long-term growth strategy is based on approximately 6% to 8%